Matarin Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-54,157	Closed	-$4.58M	–	277
2018 Q4	$4.58M	Sell	54,157 -9,243	-15%	-$985K	0.37%	98
2018 Q3	$10.9M	Sell	63,400 -2,645	-4%	-$399K	0.7%	58
2018 Q2	$8.54M	Sell	66,045 -8,823	-12%	-$985K	0.62%	66
2018 Q1	$7.71M	Sell	74,868 -1,534	-2%	-$152K	0.58%	65
2017 Q4	$6.53M	Buy	76,402 +33,398	+78%	+$2.89M	0.51%	70
2017 Q3	$3.65M	Buy	43,004 +18,677	+77%	+$1.48M	0.31%	130
2017 Q2	$1.84M	Sell	24,327 -39,463	-62%	-$2.76M	0.17%	159
2017 Q1	$4.21M	Sell	63,790 -17,838	-22%	-$1.17M	0.41%	89
2016 Q4	$5.17M	Sell	81,628 -26,764	-25%	-$1.69M	0.58%	55
2016 Q3	$6.9M	Buy	108,392 +4,827	+5%	+$354K	0.76%	41
2016 Q2	$7.71M	Buy	103,565 +46,803	+82%	+$3.47M	1.05%	12
2016 Q1	$3.79M	Buy	56,762 +27,733	+96%	+$1.69M	0.53%	81
2015 Q4	$1.96M	Buy	29,029 +24,159	+496%	+$1.49M	0.29%	130
2015 Q3	$260K	Buy	+4,870	New	+$295K	0.05%	201
2014 Q3	–	Sell	-25,167	Closed	-$978K	–	176
2014 Q2	$978K	Buy	25,167 +7,749	+44%	+$314K	0.44%	106
2014 Q1	$731K	Sell	17,418 -199	-1%	-$8.29K	0.43%	86
2013 Q4	$578K	Buy	+17,617	New	+$574K	0.36%	98